The IMPACT Study: Personalized Physical Therapy for Better Recovery and a Stronger Core After Hernia Surgery.
Launched by THOMAS JEFFERSON UNIVERSITY ·
Trial Information
Current as of November 07, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, called the IMPACT Study, is looking at whether a personalized physical therapy program can help people recover better after surgery to fix a ventral hernia, which is a type of hernia in the abdominal area. The study focuses on adults aged 18 to 75 who have a hernia between 4 and 10 centimeters in size and are scheduled for planned hernia repair surgery. Researchers want to see if tailored physical therapy can improve core strength, stability, and movement more than the usual care patients receive, as well as if it can reduce pain, improve quality of life, and lower the chance of complications like bowel problems over the year following surgery. They are also interested in whether this approach might save costs by reducing the need for extra healthcare.
If you join the study, you will be randomly placed into one of two groups. One group will get the usual care, which includes standard advice on things like wearing a support binder, safe lifting, and slowly returning to normal activities after surgery. The other group will start with the usual care for the first two weeks but then receive six personalized physical therapy sessions over the next ten weeks. These sessions will be adjusted based on how you’re doing, focusing on improving your symptoms, movement, and overall function. The study will check your progress at two weeks, three months, and one year after surgery through physical tests, questionnaires, and interviews to understand your recovery experience. This study is not yet recruiting participants but aims to help find better ways to support hernia recovery in the future.
Gender
ALL
Eligibility criteria
About Thomas Jefferson University
Thomas Jefferson University is a distinguished academic institution located in Philadelphia, Pennsylvania, renowned for its commitment to advancing healthcare through research and education. As a clinical trial sponsor, the university leverages its extensive resources and interdisciplinary expertise to conduct innovative research aimed at improving patient outcomes. With a focus on translational medicine, Thomas Jefferson University collaborates with various stakeholders, including healthcare professionals, industry partners, and regulatory agencies, to ensure the highest standards of scientific rigor and ethical conduct in its clinical trials. The institution is dedicated to fostering a culture of excellence in research, ultimately contributing to the advancement of medical knowledge and the development of novel therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Christopher Keating
Principal Investigator
Thomas Jefferson University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported